PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för tandospirone citrate. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

10 hits

Bibliografisk träff 2019-04-30

A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China.

Chen H, Lin Q, Lin T, Lin Y, Lin X, Chen R, Luo L, Lin F, Xiao Y.

J Psychiatr Res · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.jpsychires.2019.04.024

Bibliografisk träff 2017-10-27

Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms.

Huang X, Yang J, Yang S, Cao S, Qin D, Zhou Y, Li X, Ye Y, Wu J.

Oncotarget · review-article; review; journal article · DOI 10.18632/oncotarget.22170

Bibliografisk träff 2009-07-28

Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.

Miwa H, Nagahara A, Tominaga K, Yokoyama T, Sawada Y, Inoue K, Ashida K, Fukuchi T, Hojo M, Yamashita H, Tomita T, Hori K, Oshima T.

Am J Gastroenterol · comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1038/ajg.2009.427

Bibliografisk träff 2002-09-01

[Serotonin syndrome caused by tandospirone citrate alone].

Tamura N, Nakazato Y, Yamamoto T, Iwasaki S, Shimazu K.

Rinsho Shinkeigaku · journal article; english abstract; case reports

Bibliografisk träff 2002-02-01

[Tandospirone citrate, a selective 5-HT1A agonist, alleviates L-DOPA-induced dyskinesia in patients with Parkinson's disease].

Kannari K, Kurahashi K, Tomiyama M, Maeda T, Arai A, Baba M, Suda T, Matsunaga M.

No To Shinkei · clinical trial; journal article; english abstract

Bibliografisk träff 2002-01-01

[Clinical effectiveness of tandospirone citrate (5-HT1A agonist) on patients with progressive supranuclear palsy].

Fujino Y, Nakajima M, Tsuboi Y, Baba Y, Yamada T.

Rinsho Shinkeigaku · evaluation study; journal article

Bibliografisk träff 2001-02-01

[A case of progressive supranuclear palsy improved with tandospirone citrate].

Iijima M, Terashi H, Iwata M.

Rinsho Shinkeigaku · journal article; english abstract; case reports

Bibliografisk träff 2000-11-01

[Effects of tandospirone citrate on frozen gait in patients with early stage of progressive supranuclear palsy, investigated by walk-induced activation single photon emission computed tomography method].

Watanabe H, Arahata Y, Tadokoro M, Kato T, Sobue G.

Rinsho Shinkeigaku · journal article; case reports

Bibliografisk träff 1993-11-01

Atypical anxiolytic profile of buspirone and a related drug, SM-3997, in a modified forced swim test employing straw suspension.

Nishimura H, Tanaka M, Tsuda A, Gondoh Y.

Pharmacol Biochem Behav · journal article · DOI 10.1016/0091-3057(93)90556-9

Bibliografisk träff 1989-02-01

[Electroencephalographic study on the central action of a new anxiolytic: 3a alpha, 4 beta, 7 beta, 7a alpha-hexahydro-2-(4-(4-(2-pyrimidinyl)-1- piperazinyl)-butyl)-4, 7-methano-1H-isoindole-1, 3(2H)-dione dihydrogen citrate (SM-3997)].

Hirose A, Sasa M, Akaike A, Takaori S.

Nihon Yakurigaku Zasshi · journal article; english abstract · DOI 10.1254/fpj.93.41